文献速递创伤与烧伤复苏、休克与脓毒症

院前创伤血液制品复苏中的钙剂补充:一项荟萃分析

Calcium during prehospital trauma blood-product resuscitation: A meta-analysis.
PubMed 文献 · Am J Emerg Med · 2026-09-20
一句话结论院前血液制品复苏后低钙血症常见(探索性合并患病率60.1%),补钙与较低低钙风险相关,但证据不足以推荐统一补钙方案。

仅2项非随机对照研究(军事队列和民用航空转运队列)显示补钙组低钙血症风险更低(RR分别为0.40和0.51,探索性合并RR 0.45,95%CI 0.33-0.61)。4项患病率研究(阈值<1.10至<1.20 mmol/L)的患病率为43.1%-65.8%,探索性合并患病率60.1%(95%CI 52.0%-67.7%)。作者指出阈值差异、采样时机不确定及临床异质性限制因果推断,不推荐统一补钙方案。

要点

  • 院前血液制品复苏后低钙血症常见:4项患病率研究阈值<1.10至<1.20 mmol/L,患病率43.1%-65.8%,探索性合并60.1%。
  • 补钙与较低低钙血症风险相关:军事队列RR 0.40(95%CI 0.27-0.61),民用航空转运队列RR 0.51(95%CI 0.32-0.82)。
  • 探索性合并RR为0.45(95%CI 0.33-0.61),但仅基于2项临床异质性大的非随机研究,不能作因果推断。
  • 采样在到达后30分钟内的2项研究,低钙血症患病率为62.9%(95%CI 58.3%-67.3%)。
  • 阈值不统一、采样与院内治疗先后关系不确定、残余混杂,均不支持统一补钙方案。

适用人群与场景

  • 成人创伤患者,接受院前血液制品复苏;纳入报告院前血液制品、钙剂给药及离子钙结局的研究。
  • 排除人群原文未提及。

诊断标准与关键阈值

  • 低钙血症定义采用各研究自定义阈值,范围为<1.10至<1.20 mmol/L(离子钙)。
  • 采样时机限定为到达后30分钟内的2项研究单独分析。

处置流程与药物剂量

  • 原文未提及具体钙剂剂量、给药途径、频次或目标值。
  • 原文未推荐统一补钙方案。

红旗征与不能漏的情况

  • 原文未提及具体红旗征或需立即处理的情况。

研究设计与关键结果

  • 仅2项非随机对照研究(军事队列和民用航空转运队列)比较补钙与未补钙,补钙组低钙血症风险更低(RR 0.40,95%CI 0.27-0.61;RR 0.51,95%CI 0.32-0.82)。
  • 探索性合并RR为0.45(95%CI 0.33-0.61)。
  • 4项患病率研究(阈值<1.10至<1.20 mmol/L)的低钙血症患病率为43.1%-65.8%,探索性合并患病率60.1%(95%CI 52.0%-67.7%),阈值分层估计为53.4%和65.6%。
  • 采样在到达后30分钟内的2项研究,患病率为62.9%(95%CI 58.3%-67.3%)。

证据类型、等级与局限

  • 证据类型:系统评价与荟萃分析,纳入研究均为观察性研究,仅2项非随机对照研究,合并分析为探索性。
  • 局限:阈值不统一、采样与院内治疗先后关系不确定、临床异质性、残余混杂,限制因果推断。

对床旁实践的改变

  • 院前血液制品复苏后应警惕低钙血症,但现有证据不足以支持统一补钙方案;补钙决策需个体化。
  • 适用人群为成人创伤接受院前血液制品复苏者;不适用人群原文未提及。
  • 常见陷阱:不同研究阈值和采样时机差异大,不能将探索性合并患病率或RR作为决策阈值。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Prehospital blood-product resuscitation may be complicated by citrate-related ionized hypocalcemia. Interpretation is limited by nonuniform thresholds and uncertainty about whether the first hospital calcium sample preceded in-hospital treatment.

OBJECTIVE: To characterize study-defined hypocalcemia after prehospital blood products and examine its association with prehospital or en-route calcium administration.

METHODS: We performed a PROSPERO-registered systematic review and meta-analysis of adult trauma studies reporting prehospital blood products, calcium administration, and ionized‑calcium outcomes. We extracted each threshold, sampling interval, and treatment before sampling. Because only two clinically dissimilar nonrandomized comparative studies were available, study-specific effects were prioritized and pooling was exploratory. Prevalence was examined overall, by threshold category, and with sampling restricted to within 30 min of arrival.

RESULTS: Seventeen studies met inclusion criteria. Calcium-exposed patients had lower observed hypocalcemia in the military cohort (risk ratio [RR] 0.40, 95% confidence interval [CI] 0.27-0.61) and civilian air-transport cohort (RR 0.51, 95% CI 0.32-0.82); the exploratory pooled RR was 0.45 (95% CI 0.33-0.61). Across four prevalence studies using thresholds from <1.10 to <1.20 mmol/L, study-specific prevalence ranged from 43.1% to 65.8%. The exploratory pooled prevalence was 60.1% (95% CI 52.0%-67.7%), with threshold-stratified estimates of 53.4% and 65.6%. In two studies with sampling within 30 min, prevalence was 62.9% (95% CI 58.3%-67.3%).

CONCLUSIONS: Hypocalcemia was frequently observed after prehospital blood-product resuscitation. Threshold variation, uncertain sampling relative to in-hospital treatment, clinical heterogeneity, and residual confounding preclude causal inference or endorsement of a uniform calcium protocol.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Cheng CY, Liang YK, Chang CJ, et al. Calcium during prehospital trauma blood-product resuscitation: A meta-analysis. Am J Emerg Med. 2026. PMID: 42784942. doi:10.1016/j.ajem.2026.09.034

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。